A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy
NCT05444257
·
clinicaltrials.gov ↗
PHASE3
Phase
ACTIVE_NOT_RECRUITING
Status
822
Enrollment
INDUSTRY
Sponsor class
Conditions
Cystic Fibrosis
Interventions
DRUG:
VX-121/TEZ/D-IVA
Sponsor
Vertex Pharmaceuticals Incorporated